Hot penny stocks... don't get burned
   

News for Javelin Pharmaceuticals, Inc (JAV)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Javelin Pharmaceuticals Inc.  (JAV) 
|
$ 1.50      0.35 (+30.43%) Volume: 592.19 k 4:03 PM EDT Oct 10, 2008
After Hours:  $ 1.50 0.00 (0.00%) Volume: 837 4:21 PM EDT Oct 10, 2008
Mon, Sep 22, 2008
7:49 AM Javelin Enrolls First Patient in an Open Label Safety Study of Dyloject(TM) - Business Wire
Wed, Sep 17, 2008
8:31 AM Javelin Pharmaceuticals to Present at the 2008 UBS Global Life Sciences Conference - Business Wire
Tue, Sep 16, 2008
8:19 AM Javelin Pharmaceuticals Completes Patient Enrollment for Second of two Pivotal Phase 3 Studies of Dyloject(TM) - Business Wire
Fri, Aug 29, 2008
10:40 AM Company Profile for Javelin Pharmaceuticals, Inc. - Business Wire
Tue, Aug 26, 2008
9:12 AM Javelin Pharmaceuticals CEO to Provide Corporate Overview at the BioCentury NewsMakers Conference - Business Wire
Thu, Aug 21, 2008
8:10 AM Javelin Presents Successful Pivotal Phase 3 Secondary Clinical Results for Dyloject(TM) at the 12th World Congress on Pain - Business Wire
Tue, Aug 12, 2008
8:37 AM Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting - Business Wire
Mon, Aug 11, 2008
8:44 AM Javelin Pharmaceuticals, Inc. to Present at 28th Annual Canaccord Adams Global Growth Conference in Boston - Business Wire
Thu, Aug 07, 2008
8:57 AM Javelin Pharmaceuticals, Inc. Reports Second Quarter 2008 Results and Corporate Highlights - Business Wire
Fri, Aug 01, 2008
8:35 AM Javelin Pharmaceuticals to Announce Second Quarter 2008 Financial Results - Business Wire
Thu, Jul 31, 2008
10:38 AM Javelin Pharmaceuticals and Baxter Healthcare Corporation Expand Commercial Supply Relationship for Anticipated Dyloject(TM) Global Growth - Business Wire
Tue, Jun 10, 2008
8:48 AM Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial for PMI-150 - Business Wire
Thu, Jun 05, 2008
9:20 AM Javelin Pharmaceuticals' Founder and President Transitions to Executive Director - Business Wire

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for JAV stock. Download JAV report.
Research Report
Get the full report for FREE
Date:Sep 4, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download JAV report
  
Example preview: Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Javelin Pharmaceuticals, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.